These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
384 related articles for article (PubMed ID: 21879389)
41. Noncoding RNA for Cancer Gene Therapy. Zhong X; Zhang D; Xiong M; Zhang L Recent Results Cancer Res; 2016; 209():51-60. PubMed ID: 28101687 [TBL] [Abstract][Full Text] [Related]
42. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Gaur A; Jewell DA; Liang Y; Ridzon D; Moore JH; Chen C; Ambros VR; Israel MA Cancer Res; 2007 Mar; 67(6):2456-68. PubMed ID: 17363563 [TBL] [Abstract][Full Text] [Related]
43. MicroRNA-206 functions as a potential oligonucleotide therapeutics in preterm birth. Deng W; Chen L; Wen B; Wang X; Wang L; Yang F; Chen Y; Bao J; Zhang G; Ji K; Liu H Chin Med J (Engl); 2024 Apr; 137(8):1000-1002. PubMed ID: 38273441 [No Abstract] [Full Text] [Related]
45. Screening of potential miRNA therapeutics for the prevention of multi-drug resistance in cancer cells. Medarova Z; Pantazopoulos P; Yoo B Sci Rep; 2020 Feb; 10(1):1970. PubMed ID: 32029822 [TBL] [Abstract][Full Text] [Related]
46. The therapeutic potential of microRNAs in cancer. Thorsen SB; Obad S; Jensen NF; Stenvang J; Kauppinen S Cancer J; 2012; 18(3):275-84. PubMed ID: 22647365 [TBL] [Abstract][Full Text] [Related]
47. MicroRNAs in cancer metastasis: biological and therapeutic implications. Sell MC; Ramlogan-Steel CA; Steel JC; Dhungel BP Expert Rev Mol Med; 2023 Mar; 25():e14. PubMed ID: 36927814 [TBL] [Abstract][Full Text] [Related]
52. Transitional Insight into the RNA-Based Oligonucleotides in Cancer Treatment. Tabasi H; Mollazadeh S; Fazeli E; Abnus K; Taghdisi SM; Ramezani M; Alibolandi M Appl Biochem Biotechnol; 2024 Mar; 196(3):1685-1711. PubMed ID: 37402038 [TBL] [Abstract][Full Text] [Related]
53. MicroRNA-143 as a new weapon against cancer: overview of the mechanistic insights and long non-coding RNA mediated regulation of miRNA-143 in different cancers. Farooqi AA; Qureshi MZ; Attar R; Alhewairini SS; Fayyaz S; Sabitaliyevich UY; Duisenbayevich TM; Alaaeddine N Cell Mol Biol (Noisy-le-grand); 2019 Jul; 65(6):1-5. PubMed ID: 31472055 [TBL] [Abstract][Full Text] [Related]
54. microRNAs: Master regulators as potential therapeutics in cancer. Garofalo M; Croce CM Annu Rev Pharmacol Toxicol; 2011; 51():25-43. PubMed ID: 20809797 [TBL] [Abstract][Full Text] [Related]
55. Advances in adenovirus-mediated p53 cancer gene therapy. Tazawa H; Kagawa S; Fujiwara T Expert Opin Biol Ther; 2013 Nov; 13(11):1569-83. PubMed ID: 24107178 [TBL] [Abstract][Full Text] [Related]
56. Applications of Extracellular RNAs in Oncology. Thompson JR; Zhu J; Kilari D; Wang L Mol Diagn Ther; 2017 Feb; 21(1):1-11. PubMed ID: 27688207 [TBL] [Abstract][Full Text] [Related]
57. Promising therapeutic role of miR-27b in tumor. Ding L; Ni J; Yang F; Huang L; Deng H; Wu Y; Ding X; Tang J Tumour Biol; 2017 Mar; 39(3):1010428317691657. PubMed ID: 28351320 [TBL] [Abstract][Full Text] [Related]
58. Determination of Anti-miR Association with miRNA/Argonaute Complexes In Vivo. Zisoulis DG Methods Mol Biol; 2017; 1517():79-89. PubMed ID: 27924475 [TBL] [Abstract][Full Text] [Related]
59. Therapeutic targeting of miRNA-216b in cancer. Jana S; Krishna M; Singhal J; Horne D; Awasthi S; Salgia R; Singhal SS Cancer Lett; 2020 Aug; 484():16-28. PubMed ID: 32387443 [TBL] [Abstract][Full Text] [Related]
60. MicroRNA epigenetic alterations in human cancer: one step forward in diagnosis and treatment. Yang N; Coukos G; Zhang L Int J Cancer; 2008 Mar; 122(5):963-8. PubMed ID: 18098137 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]